| Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4 Z Wang, VH Wu, MM Allevato, M Gilardi, Y He, J Luis Callejas-Valera, ... Nature communications 10 (1), 5546, 2019 | 132 | 2019 |
| Wnt modulates MCL1 to control cell survival in triple negative breast cancer L Yang, AA Perez, S Fujie, C Warden, J Li, Y Wang, B Yung, YR Chen, ... BMC cancer 14, 1-13, 2014 | 81 | 2014 |
| Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC R Saddawi-Konefka, A O’Farrell, F Faraji, L Clubb, MM Allevato, ... Nature communications 13 (1), 4298, 2022 | 67 | 2022 |
| PLCε, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart SY Xiang, K Ouyang, BS Yung, S Miyamoto, AV Smrcka, J Chen, ... Science signaling 6 (306), ra108-ra108, 2013 | 66 | 2013 |
| Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer Z Wang, Y Goto, MM Allevato, VH Wu, R Saddawi-Konefka, M Gilardi, ... Nature communications 12 (1), 2383, 2021 | 47 | 2021 |
| Selective coupling of the S1P3 receptor subtype to S1P-mediated RhoA activation and cardioprotection BS Yung, CS Brand, SY Xiang, CBB Gray, CK Means, H Rosen, J Chun, ... Journal of molecular and cellular cardiology 103, 1-10, 2017 | 45 | 2017 |
| Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection X Zhao, EY Ding, MY Olivia, SY Xiang, VP Tan-Sah, BS Yung, J Hedgpeth, ... Journal of molecular and cellular cardiology 75, 152-161, 2014 | 43 | 2014 |
| Molecular properties, functional mechanisms, and applications of sliced siRNA G Sun, SY Yeh, CWY Yuan, MJY Chiu, BSH Yung, Y Yen Molecular Therapy-Nucleic Acids 4, 2015 | 33 | 2015 |
| The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure VH Wu, BS Yung, F Faraji, R Saddawi-Konefka, Z Wang, AT Wenzel, ... Nature immunology 24 (8), 1318-1330, 2023 | 18 | 2023 |
| Adipose tissue: a new target for electroporation-enhanced DNA vaccines PD Fisher, CJ Brambila, JR McCoy, WB Kiosses, JM Mendoza, J Oh, ... Gene Therapy 24 (12), 757-767, 2017 | 17 | 2017 |
| Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin K Schultheis, H Schaefer, BS Yung, J Oh, K Muthumani, L Humeau, ... Vaccine 35 (1), 61-70, 2017 | 16 | 2017 |
| Active immunoprophylaxis and vaccine augmentations mediated by a novel plasmid DNA formulation NN Schommer, J Nguyen, BS Yung, K Schultheis, K Muthumani, ... Human Gene Therapy 30 (4), 523-533, 2019 | 13 | 2019 |
| Protection against Borreliella burgdorferi infection mediated by a synthetically engineered DNA vaccine GH Guibinga, B Sahay, H Brown, N Cooch, J Chen, J Yan, C Reed, ... Human Vaccines & Immunotherapeutics 16 (9), 2114-2122, 2020 | 7 | 2020 |
| Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity K Schultheis, HM Pugh, J Oh, J Nguyen, B Yung, C Reed, N Cooch, ... Human Vaccines & Immunotherapeutics 16 (9), 2165-2175, 2020 | 6 | 2020 |
| Novel IFN-γ ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits BS Yung, H Pugh, AA Generotti, N Phanhthilath, K Schultheis, ... Vaccine 37 (7), 903-909, 2019 | 4 | 2019 |
| Optimized interferon-gamma ELISpot assay to measure T cell responses in the guinea pig model after vaccination K Schultheis, H Schaefer, HM Pugh, BS Yung, J Oh, J Nguyen, L Humeau, ... JoVE (Journal of Visualized Experiments), e58595, 2019 | 4 | 2019 |
| Exploiting Next-Generation Preclinical Syngeneic Models to Enhance Responses to Cancer Immunotherapy BSH Yung UC San Diego, 2024 | | 2024 |
| Research briefing AY Sung, DJ Pagliarini Nature Immunology 24, 1232-1233, 2023 | | 2023 |
| A chemogenetic approach reveals a GPCR-Gαs-PKA signaling axis promoting T cell dysfunction and cancer immunotherapy failure BS Yung, VH Wu, F Faraji, R Saddawi-Konefka, Z Wang, AT Wenzel, ... Cancer Research 83 (7_Supplement), 2868-2868, 2023 | | 2023 |
| In vivo use of chondroitinase and/or hyaluronidase to enhance delivery of an agent T Smith, N Schommer, K Broderick, Y Bryan, K Schultheis US Patent App. 18/060,048, 2023 | | 2023 |
